PHI with Pancreatic sarcoma excision
How does this condition affect your private health insurance?
Pancreatic sarcoma is an exceedingly rare and aggressive malignant tumor originating from the connective tissues of the pancreas, distinct from the more common adenocarcinoma. Its removal, often referred to as a pancreatectomy, is a highly complex and extensive surgical procedure. This may involve a Whipple procedure, excising parts of the pancreas, duodenum, gallbladder, and bile duct, or a distal pancreatectomy. This radical intervention is critical due to the tumor's rapid growth and high metastatic potential. Post-operative recovery is challenging, frequently necessitating intensive care, prolonged hospitalization, and long-term management to address potential digestive and endocrine dysfunctions. Despite aggressive treatment, the overall prognosis remains guarded.
PKV Risk Assessment
Individual, specialized PHI providers may still insure you, but with a significant surcharge.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Months to a year, often asymptomatic until advanced stages of tumor growth
Duration of Illness (Lifetime)
One-time event if successfully treated without recurrence; otherwise, chronic and life-limiting due to recurrence or progression
Cost of Treatment (Initial)
High (€50,000 - €200,000+ for complex surgery and immediate post-operative care)
Cost of Treatment (Lifetime)
Very high (€100,000 - €500,000+, including follow-up, potential chemotherapy, radiation, and supportive care for complications or recurrence)
Mortality Rate
Moderate to high (e.g., 30-70% within 5 years, even with successful surgery, due to the aggressive nature and high recurrence rates)
Risk of Secondary Damages
High (e.g., 60-90% for surgical complications like fistula, infections, bleeding; long-term digestive issues, diabetes, pain, and psychological distress)
Probability of Full Recovery
Low (e.g., 10-30% for long-term, disease-free survival without significant enduring consequences)
Underlying Disease Risk
Low to moderate (e.g., 5-15% for pre-existing conditions complicating surgery or recovery; not typically caused by other specific underlying diseases)